UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027777
Receipt number R000031826
Scientific Title Development of algorithms to identify Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japanese
Date of disclosure of the study information 2017/08/01
Last modified on 2017/11/04 22:15:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of algorithms to identify Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japanese

Acronym

Development of algorithms to identify SJS and TEN

Scientific Title

Development of algorithms to identify Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japanese

Scientific Title:Acronym

Development of algorithms to identify SJS and TEN

Region

Japan


Condition

Condition

skin disease:
Stevens-Johnson Syndrome(SJS)
Toxic Epidermal Necrolysis(TEN)
Erythema Multiforme major(EM major)
Staphylococcal Scalded Skin Syndrome(SSSS)
Toxicodermia
fixed drug eruption
Drug-induced hypersensitivity syndrome(DIHS)
impetigo contagiosa
Acute Generalized Exanthematous Pustulosis(AGEP)
paraneoplastic pemphigus

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to develop algorithms to identify SJS and TEN based on electronic medical records. Developed algorithms are applied to a large scale medical information database, to distinguish SJS and TEN from other diseases.

Basic objectives2

Others

Basic objectives -Others

Validity of developed algorithms

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Sensitivity, specificity and positive predictive value(PPV)

Key secondary outcomes

None


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with diseases specified in Condition.

Key exclusion criteria

Patients concomitantly affected with SJS/TEN and DIHS.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hisashi Urushihara

Organization

Faculty of Pharmacy, Keio University

Division name

Department of Drug Development and Regulatory Science

Zip code


Address

1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512 Japan

TEL

03-5400-2649

Email

urushihara-hs@pha.keio.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hisashi Urushihara

Organization

Faculty of Pharmacy, Keio University

Division name

Department of Drug Development and Regulatory Science

Zip code


Address

1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512 Japan

TEL

03-5400-2649

Homepage URL


Email

urushihara-hs@pha.keio.ac.jp


Sponsor or person

Institute

Department of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of Dermatology, Faculty of Medicine, Keio University

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 07 Month 31 Day

Date of IRB


Anticipated trial start date

2017 Year 08 Month 01 Day

Last follow-up date

2017 Year 08 Month 31 Day

Date of closure to data entry

2017 Year 09 Month 30 Day

Date trial data considered complete

2017 Year 10 Month 31 Day

Date analysis concluded

2022 Year 03 Month 31 Day


Other

Other related information

Study design:
Validation study

We use electronic medical records in Keio University Hospital and assess the validity of algorithms to identify incident SJS/TEN patients.


Management information

Registered date

2017 Year 06 Month 16 Day

Last modified on

2017 Year 11 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031826


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name